Clinical Trials Logo

Clinical Trial Summary

Hypothesis: Individuals presenting with prenatal alcohol exposure (PEA) show emotional abilities deficits, and imbalance between the two systems involved in decision-making according to dual-process models, namely an under-activated reflective system (involved in deliberate behaviors) and an over-activated affective-automatic one (involved in impulsive behaviors). Primary objective: To explore performance (as a percentage of correct answers) in an emotional facial expression decoding task in PEA participants compared to controls without alcohol disorder.


Clinical Trial Description

Each participant will undergo 2 visits : First visit : - Checking inclusion and non-inclusion criteria - Note of information and consent form - Record of concomitant treatments and anamnestic elements - Alcohol, Tobacco, and Toxic Consumption - Urinary Toxicity Test for Control Groups - Laterality test (Hecaen, 1984) - Brief visual and auditory acuity test - Standardized psychiatric interview (Mini International Neuropsychiatric Interview - MINI) Second visit = Experimental testing - State-Trait Anxiety Inventory, Beck Depression Inventory, Inventory of Interpersonal Problems, Toronto Alexithymia Scale (TAS-20). - Participant installation and testing: 6 behavioral tasks on a computer (also used to collect responses, except for task 2, see details below) : Task 1 (MAIN): Test for recognition of facial emotions Task 2: 'Reading the Mind in the Eyes Test' (Decoding of complex emotional states) Task 3: Emotional evaluation of natural scenes Task 4: Target detection (measure of attentional bias towards alcohol-related stimuli) Task 5: Go / No-Go evaluating the interactions between inhibition processes and auto-affective system Task 6: "N-back" evaluating the interactions between working memory and automatic-affective system ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03793920
Study type Interventional
Source University Hospital, Lille
Contact
Status Active, not recruiting
Phase N/A
Start date November 8, 2018
Completion date November 11, 2022

See also
  Status Clinical Trial Phase
Completed NCT01911299 - Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders Phase 2
Completed NCT03633149 - Choices4Health: Intervention to Prevent Substance-exposed Pregnancy N/A
Completed NCT01149538 - Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure Phase 1/Phase 2